CRBP - Corbus Pharmaceuticals Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5365.28M
Enterprise Value 3304.37M
Trailing P/E N/A
Forward P/E 1-3.45
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)10.74
Price/Book (mrq)7.71
Enterprise Value/Revenue 38.95
Enterprise Value/EBITDA 6-5.37

Trading Information

Stock Price History

Beta (3Y Monthly) 1.45
52-Week Change 314.40%
S&P500 52-Week Change 32.16%
52 Week High 39.11
52 Week Low 34.80
50-Day Moving Average 36.17
200-Day Moving Average 36.94

Share Statistics

Avg Vol (3 month) 3686.57k
Avg Vol (10 day) 3843.58k
Shares Outstanding 555.6M
Float 56.11M
% Held by Insiders 15.45%
% Held by Institutions 144.44%
Shares Short (Jul 31, 2019) 416.17M
Short Ratio (Jul 31, 2019) 434.5
Short % of Float (Jul 31, 2019) 427.48%
Short % of Shares Outstanding (Jul 31, 2019) 425.02%
Shares Short (prior month Jun 28, 2019) 416.29M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -164.68%
Operating Margin (ttm)-168.56%

Management Effectiveness

Return on Assets (ttm)-46.39%
Return on Equity (ttm)-108.87%

Income Statement

Revenue (ttm)34M
Revenue Per Share (ttm)0.56
Quarterly Revenue Growth (yoy)3,308.30%
Gross Profit (ttm)-43.79M
EBITDA -56.71M
Net Income Avi to Common (ttm)-55.99M
Diluted EPS (ttm)-0.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)73.15M
Total Cash Per Share (mrq)1.13
Total Debt (mrq)7.72M
Total Debt/Equity (mrq)16.29
Current Ratio (mrq)2.56
Book Value Per Share (mrq)0.73

Cash Flow Statement

Operating Cash Flow (ttm)-28.98M
Levered Free Cash Flow (ttm)-9.49M